ENTERO HEALTHCARE SOLU L Share Price
ENTERO HEALTHCARE SOLU L Share Price Today
As of 5 Jul 2026, ENTERO HEALTHCARE SOLU L share price is ₹1,212.40. The stock opened at ₹1,200.00, compared to its previous close of ₹1,194.30. During today's trading session, ENTERO HEALTHCARE SOLU L share price moved in the range of ₹1,193.00 to ₹1,228.50, with an average price of ₹1,210.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹944.00 and a high of ₹1,390.00. On the performance front, ENTERO HEALTHCARE SOLU L share price has increased by 7.91% over the last six months and is down 0.39% on a year-on-year basis.
ENTERO HEALTHCARE SOLU L Returns Calculator
ENTERO HEALTHCARE SOLU L Shareholder Returns
ENTERO HEALTHCARE SOLU L Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
ENTERO HEALTHCARE SOLU L Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹5,095.78 | ₹3,922.31 | ₹3,300.21 | ₹2,522.07 |
| Other Income | ₹39.51 | ₹14.41 | ₹5.51 | ₹4.48 |
| Total Revenue | ₹5,135.29 | ₹3,936.72 | ₹3,305.72 | ₹2,526.55 |
| Total Expenses | ₹4,996.55 | ₹3,901.17 | ₹3,309.41 | ₹2,546.36 |
| Profit Before Tax | ₹138.74 | ₹35.56 | -₹3.69 | -₹19.81 |
| Tax | ₹31.31 | -₹4.24 | ₹7.42 | ₹9.63 |
| Profit After Tax | ₹107.43 | ₹39.80 | -₹11.10 | -₹29.44 |
| EPS - Basic | ₹21.80 | ₹10.81 | -₹0.18 | -₹191.90 |
| EPS - Diluted | ₹21.76 | ₹10.81 | -₹0.18 | -₹191.90 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹138.74 | ₹35.56 | -₹3.69 | -₹19.81 |
| Income before WC changes | ₹182.79 | ₹122.17 | ₹67.47 | ₹21.71 |
| Change in Assets | -₹299.88 | -₹142.49 | -₹152.98 | -₹95.05 |
| Change in Liabilities | ₹78.36 | -₹3.24 | ₹52.62 | ₹48.98 |
| Change in WC | -₹221.52 | -₹145.73 | -₹100.36 | -₹46.07 |
| Cash flow from Operations | -₹76.87 | -₹36.61 | -₹45.32 | -₹35.27 |
| Cash flow from Investing | ₹219.80 | -₹705.12 | -₹48.60 | -₹161.73 |
| Cash flow from Financing | -₹73.66 | ₹862.94 | ₹72.76 | ₹211.19 |
| Total Cash Flow | ₹69.27 | ₹121.21 | -₹21.15 | ₹14.19 |
| Cash (Start of the year) | ₹147.65 | ₹25.36 | ₹46.51 | ₹32.31 |
| Cash (End of the year) | ₹229.28 | ₹147.65 | ₹25.36 | ₹46.51 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹626.81 | ₹334.00 | ₹285.56 | ₹275.10 |
| Current Assets | ₹2,075.71 | ₹2,010.98 | ₹1,023.17 | ₹850.88 |
| Total Assets | ₹2,702.52 | ₹2,344.98 | ₹1,308.73 | ₹1,125.98 |
| Current Liabilities | ₹845.02 | ₹601.94 | ₹623.96 | ₹461.78 |
| Net Current Asset | ₹1,230.69 | ₹1,409.03 | ₹399.21 | ₹389.10 |
| Non-Current Liabilities | ₹87.14 | ₹101.65 | ₹87.11 | ₹100.99 |
| Equity Capital | ₹1,770.36 | ₹1,641.38 | ₹597.66 | ₹563.22 |
| Total Equity & Liabilities | ₹2,702.52 | ₹2,344.98 | ₹1,308.73 | ₹1,125.98 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹408.67 | ₹318.16 | ₹177.69 | ₹137.29 |
| Other Income | ₹114.37 | ₹89.93 | ₹52.57 | ₹26.87 |
| Total Revenue | ₹523.04 | ₹408.09 | ₹230.26 | ₹164.16 |
| Total Expenses | ₹449.18 | ₹383.72 | ₹242.71 | ₹205.01 |
| Profit Before Tax | ₹26.78 | ₹24.37 | -₹12.46 | -₹40.85 |
| Tax | ₹7.60 | -₹14.08 | ₹0.00 | ₹0.00 |
| Profit After Tax | ₹19.18 | ₹38.44 | -₹12.46 | -₹40.85 |
| EPS - Basic | ₹4.41 | ₹10.63 | -₹0.19 | -₹0.72 |
| EPS - Diluted | ₹4.40 | ₹10.63 | -₹0.19 | -₹0.72 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹26.78 | ₹24.37 | -₹12.46 | -₹40.85 |
| Income before WC changes | -₹18.05 | -₹14.07 | -₹41.97 | -₹50.22 |
| Change in Assets | -₹104.65 | -₹75.26 | -₹33.39 | -₹15.78 |
| Change in Liabilities | ₹30.34 | ₹15.47 | ₹20.98 | ₹22.27 |
| Change in WC | -₹74.31 | -₹59.79 | -₹12.41 | ₹6.49 |
| Cash flow from Operations | -₹109.02 | -₹75.65 | -₹56.91 | -₹44.70 |
| Cash flow from Investing | ₹207.75 | -₹762.69 | -₹58.29 | -₹68.80 |
| Cash flow from Financing | -₹40.89 | ₹925.56 | ₹91.11 | ₹127.48 |
| Total Cash Flow | ₹57.84 | ₹87.22 | -₹24.09 | ₹13.98 |
| Cash (Start of the year) | ₹93.34 | ₹6.12 | ₹30.20 | ₹16.22 |
| Cash (End of the year) | ₹151.18 | ₹93.34 | ₹6.12 | ₹30.20 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹994.07 | ₹107.60 | ₹90.56 | ₹96.82 |
| Current Assets | ₹809.46 | ₹1,660.99 | ₹673.00 | ₹557.27 |
| Total Assets | ₹1,803.53 | ₹1,768.58 | ₹763.57 | ₹654.08 |
| Current Liabilities | ₹129.93 | ₹127.82 | ₹134.60 | ₹79.96 |
| Net Current Asset | ₹679.53 | ₹1,533.16 | ₹538.40 | ₹477.31 |
| Non-Current Liabilities | ₹23.22 | ₹14.35 | ₹45.23 | ₹22.92 |
| Equity Capital | ₹1,650.38 | ₹1,626.41 | ₹583.73 | ₹551.21 |
| Total Equity & Liabilities | ₹1,803.53 | ₹1,768.58 | ₹763.57 | ₹654.08 |
About ENTERO HEALTHCARE SOLU L
Entero Healthcare Solutions Limited is an India-based technology-driven and integrated healthcare products distribution company. It offers a range of pharmaceuticals and other healthcare products to approximately 86,200 retail pharmacies and healthcare practitioners (HCPs) across 492 districts in India. Its portfolio includes over 68,900 SKUs from more than 2000 pharma companies. The Company is a supplier to over 3,500 hospitals across India, including corporate hospital chains. It has over a network of 104 warehouses. Its technology solutions include Entero Direct, Entero CRM, Entero ERP, and Teqtic. Its Entero Direct platform is a cloud-based software-as-a-service solution that allows retailers to order their procurement needs. The Entero CRM application is a customer relationship management tool that manages and analyzes its interactions with customers, in order to customer retention and wallet share. It also offers its products through the Aayu Chemist app and Medcords platform.
ENTERO HEALTHCARE SOLU L Financial Highlights
- Revenue: ENTERO HEALTHCARE SOLU L reported revenue of ₹6,610.45 crore in FY26 vs ₹5,135.29 crore in FY25. It showed an increase of 28.73% on a yearly basis.
- Operating Profit: ENTERO HEALTHCARE SOLU L reported an operating profit of ₹179.34 crore in FY26 vs ₹138.74 crore in FY25. It showed an increase of 29.26% on a year-on-year basis.
- Net Profit: ENTERO HEALTHCARE SOLU L reported a net profit of ₹145.84 crore in FY26 vs ₹107.43 crore in FY25. It showed an increase of 35.75% on a yearly basis.
ENTERO HEALTHCARE SOLU L Quarterly Result Highlights
- ENTERO HEALTHCARE SOLU L reported revenue of ₹1,913.94 crore in Mar 2026, compared with ₹1,711.13 crore in Dec 2025, representing an increase of 11.85% on a quarter-on-quarter (QoQ) basis.
- ENTERO HEALTHCARE SOLU L reported an operating profit of ₹57.95 crore in Mar 2026, compared with ₹40.40 crore in Dec 2025, representing an increase of 43.44% on a quarter-on-quarter (QoQ) basis.
- ENTERO HEALTHCARE SOLU L reported a profit of ₹45.13 crore in Mar 2026, compared with ₹33.88 crore in Dec 2025, reflecting an increase of 33.21% on a QoQ basis.
- The earnings per share (EPS) of ENTERO HEALTHCARE SOLU L stood at ₹21.80 during Mar 2026.
Similar Stocks
FAQs on ENTERO HEALTHCARE SOLU L Share Price
What is ENTERO HEALTHCARE SOLU L share price today?
ENTERO HEALTHCARE SOLU L share price is ₹1,212.40 as on 03 Jul, 2026, 15:42 IST.
How has the ENTERO HEALTHCARE SOLU L share price performed in the past?
In the last 1 year, ENTERO HEALTHCARE SOLU L delivered a return of -0.39%. The ENTERO HEALTHCARE SOLU L share price hit a high of ₹1,390.00 and low of ₹944.00.
How much is the Mutual Fund shareholding in ENTERO HEALTHCARE SOLU L shares?
The Mutual Fund Shareholding in ENTERO HEALTHCARE SOLU L was 9.52% at the end of Mar 2026.
What is the the 52-week high and low of ENTERO HEALTHCARE SOLU L shares ?
The 52-week high and low of ENTERO HEALTHCARE SOLU L share is ₹1,390.00 and ₹944.00 as of 03 Jul, 2026.
What is the market cap of ENTERO HEALTHCARE SOLU L?
The market capitalisation of ENTERO HEALTHCARE SOLU L is ₹5,191.65 Crores as on 03 Jul, 2026.
What are the stock symbols of ENTERO HEALTHCARE SOLU L?
The stock symbol of ENTERO HEALTHCARE SOLU L is ENTERO on the NSE, 544122 on the BSE, and the ISIN is INE010601016.
What was yesterday's closing price of ENTERO HEALTHCARE SOLU L shares ?
ENTERO HEALTHCARE SOLU L shares closed yesterday at ₹1,194.30 on NSE & ₹1,192.85 on BSE
How to buy ENTERO HEALTHCARE SOLU L shares?
To buy ENTERO HEALTHCARE SOLU L shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy ENTERO HEALTHCARE SOLU L shares on Holidays?
No, shares of ENTERO HEALTHCARE SOLU L or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell ENTERO HEALTHCARE SOLU L shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of ENTERO HEALTHCARE SOLU L?
The PE and PB ratio of ENTERO HEALTHCARE SOLU L is 35.6 and 3.07 respectively, as on 03 Jul, 2026, 15:42 IST.